Key Insights

Highlights

Success Rate

78% trial completion

Published Results

23 trials with published results (22%)

Research Maturity

54 completed trials (51% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 49/100

Termination Rate

14.2%

15 terminated out of 106 trials

Success Rate

78.3%

-8.2% vs benchmark

Late-Stage Pipeline

18%

19 trials in Phase 3/4

Results Transparency

43%

23 of 54 completed with results

Key Signals

23 with results78% success15 terminated

Data Visualizations

Phase Distribution

95Total
Not Applicable (34)
Early P 1 (1)
P 1 (12)
P 2 (29)
P 3 (15)
P 4 (4)

Trial Status

Completed54
Unknown23
Terminated15
Withdrawn7
Recruiting5
Not Yet Recruiting1

Trial Success Rate

78.3%

Benchmark: 86.5%

Based on 54 completed trials

Clinical Trials (106)

Showing 20 of 20 trials
NCT03581773Phase 2RecruitingPrimary

Folic Acid Supplement Versus Placebo for Treating Mucositis Adverse Events in Metastatic Renal Cell Carcinoma Patients Receiving Targeted Therapy

NCT05635929Not ApplicableRecruiting

Effect of a Novel Topical Composition on the Incidence of Severe Oral Mucositis in Head & Neck Cancer Radiated Patients and Quality of Life Assessed by PROMs.

NCT02671812Completed

Outcome After Dental Implant Treatment

NCT06481254Not ApplicableCompletedPrimary

Effect of Hawthorn Vinegar, Black Mulberry Syrup and Green Tea on Oral Mucositis

NCT07053969Not ApplicableRecruiting

The Effect Of Enamel Matrix Derivatives On Gingival Tissue Thickness

NCT06725095Not ApplicableEnrolling By InvitationPrimary

Effects of Enamel Matrix Derivative in the Treatment of Peri-implant Mucositis

NCT01085617Completed

Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic Leukemia

NCT03480971Phase 2RecruitingPrimary

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

NCT06599346Not ApplicableRecruitingPrimary

Effects of Mesenchymal Stem Cell Supernatant on Prevention and Treatment of Skin/Mucosal Injury in Hematology Patients

NCT06117904Not ApplicableCompleted

Adjunctive Treatments for the Prevention of Radiotherapy-Induced Mucositis

NCT06521112Not ApplicableCompletedPrimary

The Effect of Oral Care on Mucositis and Oral Mucosa According to Individual Oral Care Frequency Assessment

NCT06472024Not ApplicableNot Yet Recruiting

Assessing Manual Acupuncture's Impact on Mucositis From Nasopharynx Cancer Radiotherapy: A Visual Analogue Scale (VAS) and Quality of Life Study

NCT05849415Completed

Periodontal Health and Its Relationship With Psychological Stress

NCT03243591Not ApplicableCompletedPrimary

Impact of Oral Hygiene Gels on Peri-implant Mucositis

NCT04046250Phase 2CompletedPrimary

Phase 2a Study to Evaluate Suppression of Methotrexate-induced Mucositis by TK112690

NCT05669521Phase 2UnknownPrimary

Phase 2a Study to Evaluate Suppression of 5-Fluorouracil -Induced Mucositis by TK112690

NCT05658016Phase 2UnknownPrimary

Phase 2a Study to Evaluate Suppression of Radiotherapy-induced Mucositis by TK112690

NCT01341054Not ApplicableCompletedPrimary

Use of Chamomilla Recutita in Mucositis

NCT05242991Not ApplicableUnknownPrimary

Effectiveness of Photobiomodulation Protocols in Radiation-induced Oral Side Effects in H&N Cancer Patients

NCT02723604Not ApplicableCompletedPrimary

Low-Level Laser Therapy for Prevention of Oral Mucositis

Scroll to load more

Research Network

Activity Timeline